CD8A and neoplasm: As shown in Fig. 2, EVPs from diABZI-treated 4T1 cells significantly reduced both tumor size and tumor weight (Fig. 2b–d) and increased the infiltration of both CD3+ and CD8+ T cells in BALB/c mice bearing subcutaneous 4T1 tumors (Fig. 2e, f).